Skip to main content
Fig. 1 | Allergy, Asthma & Clinical Immunology

Fig. 1

From: Letting the patients speak: an in-depth, qualitative research-based investigation of factors relevant to health-related quality of life in real-world patients with hereditary angioedema using subcutaneous C1 inhibitor replacement therapy

Fig. 1

Conceptual model of HRQoL-related themes identified from interviews of 14 patients with HAE-C1INH using C1INH(SC) replacement therapy. The model included concepts which were identified by 5 or more patients during the interviews. Each box represents a theme; bulleted items are concepts. N values are number of patient interviews in which concept was mentioned. The conceptual model concluded that the themes of improved HAE symptoms and lessened impact of HAE attack triggers (center circle) impacted improvements in other themes. AE-QoL Angioedema Quality of Life, ER emergency room, HAE hereditary angioedema, HCP health care practitioner, HRQoL health-related quality of life, C1INH C1 inhibitor, C1INH(SC) subcutaneous C1INH. aConcept included even though it was mentioned in less than n = 5 patient interviews because it relates to an item in the AE-QOL

Back to article page